Rocket Pharmaceuticals, Cranbury, NJ

Rocket Pharmaceuticals

www.rocketpharma.com

Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company advancing numerous gene therapies that could cure rare childhood diseases. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for seeking gene therapy cures for devastating diseases and making a difference for patients. Become an integral part of a small, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. ...

More>>

Number of Employees: 100-250
Annual Revenue: $10-50 Million

www.rocketpharma.com
9 Cedarbrook Drive
Cranbury, NJ USA 08512
Phone: 646.440.9100

Name	Title	Contact Details
Kinnari Patel	President, Head of Research & Development and Chief Operating Officer	Profile
Chris Stevens	Chief Operating Officer	Profile
Chantal Petit	VP, Chief of Staff supporting the President/Head R&D/COO at Rocket Pharmaceuticals	Profile
Mayo Pujols	Executive Vice President and Chief Technical Officer	Profile

Similar Companies

Avalyn Pharma

Avalyn is a biopharma company committed to developing improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. Our lead asset is inhaled pirfenidone (AP01) for the treatment of IPF. With offices in Seattle and San Diego, Avalyn`s experienced clinical and inhaled product development team is rapidly advancing AP01 for the treatment of IPF and additional pipeline candidates for IPF and other severe respiratory diseases.

Myriant Technologies

At Myriant, we know there`s a better, greener way to produce the products people use every day. And we`re realizing that vision—displacing barrels of petroleum by manufacturing and selling high-value chemicals made from renewable, sustainable feedstocks. As companies and consumers look for ways to reduce their carbon footprint and transition away from petroleum`s price volatility, Myriant has the solution: our proven technology platform and strategic feedstock selection enable Myriant to deliver high-quality, high-performing, green chemicals at a competitive, more-predictable cost versus petroleum-based chemicals without the need for government subsidies. That`s what we call a sustainable advantage.

CTOs on the Move